VERO Venus Concept Inc.
Healthcare$0.31+2.64%ClosedMarket Cap: $578,187
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.22
P/S
0.01
EV/EBITDA
-0.60
DCF Value
$-290.95
FCF Yield
-3588.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
64.4%
Operating Margin
-59.0%
Net Margin
-92.8%
ROE
-2268.3%
ROA
-88.6%
ROIC
-93.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $13.8M | 64.0% | $-9.5M | $-22.6M | $— | — |
| Q2 null | $15.7M | 60.1% | $-9.0M | $-11.7M | $— | — |
| Q1 null | $13.6M | 64.2% | $-9.5M | $-12.4M | $— | — |
| Q4 null | $15.8M | 69.1% | $-6.7M | $-8.0M | $— | — |
| FY null | $64.8M | 68.3% | $-27.2M | $-47.0M | $— | — |
| Q3 null | $15.0M | 66.1% | $-7.2M | $-9.3M | $— | — |
| Q2 null | $16.6M | 71.5% | $-5.6M | $-20.0M | $— | — |
| Q1 null | $17.5M | 66.6% | $-7.8M | $-9.8M | $— | — |
| Q4 null | $18.1M | 66.5% | $-7.6M | $-11.1M | $— | — |
| FY null | $76.4M | 68.3% | $-28.3M | $-37.3M | $— | — |
| Q3 2023 | $17.6M | 69.2% | $-6.8M | $-9.1M | $-1.64 | — |
| Q2 2023 | $20.1M | 70.8% | $-5.8M | $-7.4M | $-1.35 | — |